- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00094250
HEARTS: Heart, Exercise, and Resistance Training Study
More Effective Exercise Modalities in Older Congestive Heart Failure Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
BACKGROUND:
The amount of functional skeletal muscle that CHF patients are able to preserve is a major independent predictor of their ability to maintain physical function. Older patients with CHF (who make up the vast majority of CHF patients) are least able to do this. The disease is marked by a loss of aerobic muscle fibers, while aging is marked by a loss of glycolytic muscle fibers. Because the disease may be physiologically different in older CHF patients than in younger ones (due to loss of both muscle types in older CHF patients), they need different therapeutic approaches. Strategy tests aimed at increasing muscle mass through resistance strength training in systolic failure patients have been rare, small, and generally lacking older participants. The studies done among younger CHF patients have shown that both aerobic, and combination aerobic and strength training can increase work capacity, oxidative muscle activity, and glycolytic muscle strength. Additionally, combination training can improve cardiac measures, including LVEF.
DESIGN NARRATIVE:
An estimated 200 participants age 65 and older with Class II and III CHF and LVEF 20% to 40% will be included in this study. Their work capacity will be measured in watts on a cycle ergometer exercise stress test (Time 1). They will be randomized by gender, race, and disease severity into two exercise groups: 1) resistance and aerobic training (RA); and 2) aerobic training (A). Both groups will exercise three times a week for 4 months. At the end of the 4 months of training, the cycle ergometer stress test will be repeated (Time 2). By comparing changes in maximum watts achieved from Time 1 to Time 2 in each group, an assessment can be made of the effectiveness of each exercise program in improving work capacity. Secondarily, measures will be performed and compared of myocardial remodeling, leg strength, and leg muscle oxidative capacity at Time 1 and Time 2. The goal of the study is to determine the following:
- If low resistance frequent repetition resistance training combined with aerobic training increases aerobic work capacity more than pure aerobic training.
- If any improvement in aerobic work capacity is due to changes in muscle fiber composition, local blood flow, arterial endothelial function, or some combination.
The study completion date listed in this record was obtained from the "Completed Date" entered in the Query View Report System (QVR).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Staten Island, New York, United States
- Staten Island University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Class II and III CHF that has been clinically stable for at least 6 months
- Systolic ejection fraction (LVEF) between 20% and 40%
- Under the care of a cardiologist who is willing to have the patient participate in the study and who will continue to follow the patient medically during his/her participation
- Willing and able to undergo the screening procedures and the 1 month observation period to determine eligibility
- Willing and able to come to the research center three times a week for 4 months to participate in an exercise program consisting of either aerobic exercise only, or aerobic exercise plus resistance training
- Able to speak and read English
- Willing to participate in the study after having the study explained to him/her and has signed an informed consent form
Exclusion Criteria:
- Eligible for a cardiac rehabilitation program under Medicare rules due to a recent acute event
- Any medical condition that would make either exercise unsafe or uncomfortable, such as symptomatic COPD, severe arthritis, severe peripheral vascular disease, unstable heart disease, uncontrolled blood pressure, or neurological conditions
- Other complicating diseases, such as severe anemia or other blood dyscrasia affecting function, chronic renal failure, progressive cancer, or unstable diabetes
- Does not otherwise meet the above inclusion criteria
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Improvement in work capacity at anaerobic threshold (measured at Month 4)
|
Secondary Outcome Measures
Outcome Measure |
---|
Improvements in muscle oxidative capacity, as measured by near infrared spectroscopy (NIRS)
|
Improvements in local muscle blood flow by NIRS and plethysmography
|
Improvement in arterial endothelial function (all measured at Month 4)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Joel Posner, MD, Chairman of Medicine, Staten Island University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1272
- R01HL071567 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Diseases
-
Baker Heart and Diabetes InstitutePrincess Alexandra Hospital, Brisbane, Australia; Royal Perth Hospital; Alice... and other collaboratorsRecruitingHeart Failure | Valve Heart DiseaseAustralia
-
Medical University of ViennaUnknownHeart Diseases | Heart Failure | Valvular Heart DiseaseAustria
-
Centre Chirurgical Marie LannelongueActive, not recruitingValvular Heart Disease | Valve Disease, Heart
-
Kathirvel SubramaniamUniversity of Maryland, Baltimore; CSL BehringRecruitingHeart Failure,Congestive | Heart Disease End StageUnited States
-
Abiomed Inc.RecruitingHeart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart FailureUnited States
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Heart Failure | Valvular Heart Disease | Biochemical DysfunctionGreece
-
Wuerzburg University HospitalRecruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseGermany
-
Yonsei UniversityCompletedMitral Valvular Heart Disease
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Resistance and Aerobic Training
-
University of BarcelonaCompleted
-
Onassis Cardiac Surgery CentreInstitute of Cardiology, Warsaw, Poland; Asklepieion Voulas General HospitalCompletedHeart FailureGreece, Poland
-
Biomedical Research Institute of New MexicoBaylor College of Medicine; National Institute on Aging (NIA)Completed
-
Riphah International UniversityRecruitingCardiovascular DiseasesPakistan
-
University of Illinois at ChicagoNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Diseases | Vascular Diseases | HypertensionUnited States
-
National Cardiovascular Center Harapan Kita Hospital...Completed
-
Nanjing University of Traditional Chinese MedicineGuangxi Medical University; Southeast University, ChinaUnknown
-
University of AarhusOxford Brookes UniversityRecruiting
-
University of Alabama at BirminghamNational Institute on Aging (NIA)Completed
-
Universita di VeronaCompleted